Yidu Tech swings to profit as AI healthcare edges toward viability
The provider of healthcare data and tools is poised to pass the breakeven point, helped by rising AI uptake, but the outlook for sustained profits remains uncertain Key Takeaways: The…
Geneplus locks onto targeted medicine for IPO pitch
After a post-Covid earnings dip, the company is seeking a stable future as a provider of data and diagnostics for precision medicine and disease prevention Key Takeaways: The company’s…
RELATED ARTICLES
-
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
2667.HK - Good Doctor Cloud Healthcare’s ailing margins belie uninspired new listing
- Chinese medicine firm seeks elusive elixir of IPO success
- JD Health’s AI push sets up a battle of the digital doctors
-
BRIEF: Distinct Healthcare launches $41 million Hong Kong IPO
2677.HK
